Financials
- Market Capitalization 2.96 B
- Employee 1 371
- Founded 2010
- CEO Emil Kakkis
- Website www.ultragenyx.com
- Headquarter Delaware, United States
- FIGI BBG001RWPDW6
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-3.43
주가매출액비율
3.1
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 1666 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.04 USD | -1.91% | -4.61% | +17.09% | +10.62% | 3.17 B USD | ||
| 1684 | ELVN Enliven Therapeutics, Inc. - Common Stock | 50.47 USD | -5.06% | +0.10% | +18.61% | +144.29% | 3.07 B USD | ||
| 1737 | BEAM Beam Therapeutics Inc. - Common Stock | 28.25 USD | -8.40% | -22.96% | -9.02% | +40.41% | 2.91 B USD | ||
| 1763 | IRON Disc Medicine, Inc. - Common Stock | 73.85 USD | -2.85% | -8.15% | +5.32% | +28.61% | 2.82 B USD |